Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Choosing the right orthodontic treatment is an important decision that affects both your oral health and your appearance. If you are considering Invisalign treatment in San Jose, you’re likely comparing clear aligners with traditional braces to find out which option best suits your needs. Understanding how each treatment works can help you make an informed choice […]

The post Aligners vs Braces: Which Orthodontic Treatment is Right for You? appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Many people believe plastic surgeons and cosmetic surgeons have the same education and training, but it is this mistaken belief that can lead to confusion and danger for any person seeking an appearance or health enhancement procedure. A board-certified plastic surgeon has special education, rigorous exams, and years of surgical training that might not be […]

The post How Does a Board-Certified Plastic Surgeon Differ from a Cosmetic Surgeon? appeared first on Medical News Bulletin.

An FDA expert panel on testosterone therapy for men expressed interest in expanding the indication for testosterone therapy, eliminating some of its contraindications and removing its status as a Schedule III controlled substance.
“Testosterone deficiency is an important medical condition that adversely affects a man’s health, quality of life and risk of mortality,” Mohit Khera, MD, MBA, MPH, professor of urology at Baylor College of Medicine and co-moderator of the panel discussion, said during the hearing. “Large randomized controlled trials and observational studies have demonstrated the

The American Cancer Society updated its guidance on cervical cancer screening, including two key changes that the organization said will improve screening compliance and reduce cancer development.
According to an American Cancer Society (ACS) press release, the guidance now includes the option of self-collection of vaginal samples for HPV testing.
The guidelines, published in CA: A Cancer Journal for Clinicians, noted that HPV screening using clinician-collected cervical specimens is preferred but that self-collected specimens are acceptable for individuals aged 25 to 65 years at an average

BOSTON — Eyes with meibomian gland dysfunction are more likely to have increased tears and lower tear film stability, possible signs of dry eye disease, according to data presented here.
The conclusion came from a study by Gurneet Kaur, an optometry student at the UC Berkeley Herbert Wertheim School of Optometry & Vision Science, and colleagues presented at Academy 2025.
Aiming to learn more about connections between dry eye disease and meibomian gland dysfunction, Kaur and colleagues conducted a secondary analysis of data from the Dry Eye Evaluation and Management (DREAM) study. The

ORLANDO — Haag-Streit has launched its Metis 3D Digital Heads-Up Module, according to a company press release.
The module (Metis HU) expands on the company’s Metis 900 ophthalmic microscope by incorporating a 3D 4K camera and 55-inch monitor and replacing a traditional eyepiece with a heads-up view. The launch was announced at the American Academy of Ophthalmology meeting in Orlando, Florida.
Mike Luley, director of global strategy and business development at Haag-Streit, told Healio that that the Metis HU remains stable throughout procedures. The module provides better visualization through a

SAN ANTONIO — Younger age at diagnosis did not appear to affect outcomes among women with breast cancer who harbor BRCA mutations, according to study results presented at San Antonio Breast Cancer Symposium.
In addition, survival did not differ between very young women — defined as 30 years or younger — and those aged 31 to 40 years.
“Age per se should not be considered a negative prognostic factor in BRCA carriers when appropriate treatment is provided,” Matteo Lambertini, MD, PhD, associate professor of medical oncology and consultant in medical oncology at University of Genova-IRCCS

The world has seen great advances in the fight against malaria in recent years, including the addition of the first antiparasitic vaccines and new classes of dual-ingredient bed nets, WHO noted in its annual malaria report.
Still, there were nearly 10 million more cases of malaria worldwide in 2024 compared with 2023, according to the report, which cited the growth of antimalarial drug resistance as a reason for stalled progress against the disease.
“Overall, there has been a decline in malaria cases and deaths over the past 20 years —which is good news,” Jane M. Carlton, PhD,

SAN ANTONIO — Adjuvant giredestrant significantly improved invasive DFS vs. standard-of-care endocrine therapy in patients with early-stage, ER-positive, HER2-negative breast cancer.
The findings were presented at San Antonio Breast Cancer Symposium.
“ER-positive, HER2-negative breast cancer accounts for the majority of early breast cancers, with endocrine therapy as the mainstay of treatment in these patients,” Aditya Bardia, MD, MPH, professor of medicine and program director of breast medical oncology at UCLA Health Jonsson Comprehensive Cancer Center, said during a press briefing.
“The last

Click here to read the Cover Story, “GLP-1s may have profound impact on total joint replacement.”
GLP-1 receptor agonists mimic the action of endogenous GLP-1, a hormone that stimulates insulin secretion, delays gastric emptying, inhibits food intake and promotes satiety.
Furthermore, there is evidence of bone metabolism modulation, where GLP-1 medications may promote osteoblastogenesis while downregulating osteoclast activity; however, the clinical implications on fracture risk remain unknown. There is also some evidence of gout flares due to metabolic shifts and increased uric acid levels